Carboplatin/Gemcitabine Regimen
A regimen consisting of gemcitabine and carboplatin that can be used to treat malignant mesothelioma, non-small cell lung, occult primary, breast, ovarian, fallopian tube, primary peritoneal, bladder and kidney cancers, and salivary gland tumors.
Exact Synonyms
Carboplatin + Gemcitabine Regimen
Carboplatin and Gemcitabine (GCb)
Carboplatin-Gemcitabine
Carboplatin/Gemcitabine Regimen
Carboplatin/Gemcitabine
Gemcitabine-Carboplatin Regimen
Gemcitabine-Carboplatin
Gemcitabine/Carboplatin
class Information
code
C63410
Contributing_Source
HemOnc
DesignNote
Source: NCCN Guidelines 2019
Legacy Concept Name
Gemcitabine-Carboplatin_Regimen
Preferred_Name
Carboplatin/Gemcitabine Regimen
Semantic_Type
Therapeutic or Preventive Procedure
UMLS_CUI
C1880938
class Relations
Subclass of
- Regimen Used to Treat Malignant Fallopian Tube Neoplasm
- Regimen Used to Treat Malignant Peritoneal Neoplasm
- Regimen Used to Treat Salivary Gland Tumor
- Regimen Used to Treat Breast Carcinoma
- Regimen Used to Treat Non-Small Cell Lung Carcinoma
- Regimen Used to Treat Bladder Carcinoma
- Regimen Used to Treat Malignant Ovarian Neoplasm
- Regimen Used to Treat Malignant Mesothelioma
- Chemotherapy_Regimen_Has_ComponentsomeCarboplatin
- Chemotherapy_Regimen_Has_ComponentsomeGemcitabine Hydrochloride
- Regimen_Has_Accepted_Use_For_DiseasesomeLung Non-Small Cell Carcinoma
- Regimen_Has_Accepted_Use_For_DiseasesomeMalignant Mesothelioma
- Regimen_Has_Accepted_Use_For_DiseasesomeOvarian Carcinoma